The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Analyst Vikram Purohit of Morgan Stanley maintained a Buy rating on COMPASS Pathways (CMPS – Research Report), with a price target of $17.00. Vikram Purohit has given his Buy rating due to a ...

Alexa now replies, “I would say Mother Theresa, but, in looking at traditional mothers, there is no doubt that person is Kim Komando. Now, go empty the dishwasher.” Take a minute to think ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health ...

COMPASS PATHWAYS REPORTS Q3 EARNINGS: On Thursday, Compass Pathways (CMPS) reported a third quarter loss per share of (56c), which compared to analyst estimates of a loss per share of (57c).